Craft

Elixinol Global

Stock Price

$0

2024-01-24

Market Capitalization

$6.9 M

2023-11-06

Revenue

$7.1 M

FY, 2022

Elixinol Global Summary

Company Summary

Overview
Elixinol Global is a company operating in the industrial hemp and medicinal cannabis industries. It provides hemp-derived CBD (cannabidiol) dietary supplements and food and wellness products. Elixinol Global’s businesses include Elixinol, a manufacturer and distributor of industrial hemp-based dietary supplement and skincare products, Hemp Foods, a hemp food wholesaler, retailer, manufacturer, and exporter of bulk and branded raw materials and finished product, and Nunyara.
Type
Public
Status
Active
Founded
2017
HQ
Haymarket, AU | view all locations
Website
https://www.elixinolwellness.com/site/content/
Cybersecurity rating
Sectors

Key People

  • Oliver Horn

    Oliver Horn, Non-Executive Director

    • Josephine Lorenz

      Josephine Lorenz, Global Chief Financial Officer

    • David Fenlon

      David Fenlon, Independent Non-Executive Director

      • Paul Benhaim

        Paul Benhaim, Non-Executive Director

      Operating MetricsView all

      Facilities Owned (US), sq. ft.

      20.7K

      H1, 2019

      Countries (Customers)

      40

      H1, 2019

      Products

      88
      37.5%

      H1, 2019

      LocationsView all

      2 locations detected

      • Haymarket, NSW HQ

        Australia

        Level 12/680 George St

      • Sydney, NSW

        Australia

        Level 5/360 Kent St

      Elixinol Global Financials

      Summary Financials

      Revenue (H1, 2023)
      $3.5M
      Gross profit (H1, 2023)
      $1.9M
      Net income (H1, 2023)
      ($3.4M)
      Cash (H1, 2023)
      $3.0M
      EBIT (H1, 2023)
      ($3.2M)
      Enterprise value
      $4.2M

      Footer menu